tiprankstipranks
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
Japanese Market

Shin Nippon Biomedical Laboratories, Ltd. (2395) Income Statement

Compare
2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Income Statement

Last quarter (Q1 2024), Shin Nippon Biomedical Laboratories, Ltd.'s total revenue was ¥5.55B, a decrease of -4.40% from the same quarter last year. In Q1, Shin Nippon Biomedical Laboratories, Ltd.'s net income was ¥122.19M. See Shin Nippon Biomedical Laboratories, Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 26.45B¥ 25.09B¥ 17.75B¥ 15.11B¥ 14.56B
Gross Profit
¥ 14.28B¥ 13.05B¥ 9.69B¥ 7.55B¥ 7.62B
Operating Expenses
¥ 10.12B¥ 7.80B¥ 5.49B¥ 5.02B¥ 5.39B
Depreciation and Amortization
¥ 1.87B¥ 1.60B¥ 1.18B¥ 1.19B¥ 1.23B
EBITDA
¥ 8.98B¥ 9.49B¥ 9.49B¥ 5.55B¥ 4.53B
Operating Income
¥ 4.16B¥ 5.25B¥ 4.20B¥ 2.53B¥ 2.23B
Other Income/Expenses
¥ 2.81B¥ 2.51B¥ 3.99B¥ 1.65B¥ 834.42M
Pretax Income
¥ 6.97B¥ 7.76B¥ 8.18B¥ 4.18B¥ 3.06B
Net Income
¥ 5.53B¥ 6.06B¥ 7.13B¥ 3.66B¥ 2.55B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 132.86¥ 145.57¥ 171.21¥ 87.96¥ 61.26
Diluted EPS
¥ 132.86¥ 145.57¥ 171.21¥ 87.96¥ 61.26
Weighted Average Shares Outstanding
41.63M 41.63M 41.63M 41.63M 41.63M
Weighted Average Shares Outstanding (Diluted)
41.63M 41.63M 41.63M 41.63M 41.63M
Currency in JPY

Shin Nippon Biomedical Laboratories, Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis